Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))

N. I. Lindeman; P. T. Cagle; M. B. Beasley; D. A. Chitale; S. Dacic; G. Giaccone; R. B. Jenkins; D. J. Kwiatkowski; J. S. Saldivar; J. Squire; E. Thunnissen; M. Ladanyi

doi:10.1097/JTO.0000000000000002

Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))

N. I. Lindeman, P. T. Cagle, M. B. Beasley, D. A. Chitale, S. Dacic, G. Giaccone, R. B. Jenkins, D. J. Kwiatkowski, J. S. Saldivar, J. Squire, E. Thunnissen, M. Ladanyi

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	1343
Number of pages	1
Journal	Journal of Thoracic Oncology
Volume	8
Issue number	10
DOIs	https://doi.org/10.1097/JTO.0000000000000002
State	Published - 2013

Access to Document

10.1097/JTO.0000000000000002

Cite this

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E., & Ladanyi, M. (2013). Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859)). Journal of Thoracic Oncology, 8(10), 1343. https://doi.org/10.1097/JTO.0000000000000002

Lindeman, N. I. ; Cagle, P. T. ; Beasley, M. B. et al. / Erratum : Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859)). In: Journal of Thoracic Oncology. 2013 ; Vol. 8, No. 10. pp. 1343.

@article{98c70aef08be4971aa46f6c151dfad45,

title = "Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))",

author = "Lindeman, {N. I.} and Cagle, {P. T.} and Beasley, {M. B.} and Chitale, {D. A.} and S. Dacic and G. Giaccone and Jenkins, {R. B.} and Kwiatkowski, {D. J.} and Saldivar, {J. S.} and J. Squire and E. Thunnissen and M. Ladanyi",

year = "2013",

doi = "10.1097/JTO.0000000000000002",

language = "English",

volume = "8",

pages = "1343",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "10",

}

Lindeman, NI, Cagle, PT, Beasley, MB, Chitale, DA, Dacic, S, Giaccone, G, Jenkins, RB, Kwiatkowski, DJ, Saldivar, JS, Squire, J, Thunnissen, E & Ladanyi, M 2013, 'Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))', Journal of Thoracic Oncology, vol. 8, no. 10, pp. 1343. https://doi.org/10.1097/JTO.0000000000000002

Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859)). / Lindeman, N. I.; Cagle, P. T.; Beasley, M. B. et al.
In: Journal of Thoracic Oncology, Vol. 8, No. 10, 2013, p. 1343.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))

AU - Lindeman, N. I.

AU - Cagle, P. T.

AU - Beasley, M. B.

AU - Chitale, D. A.

AU - Dacic, S.

AU - Giaccone, G.

AU - Jenkins, R. B.

AU - Kwiatkowski, D. J.

AU - Saldivar, J. S.

AU - Squire, J.

AU - Thunnissen, E.

AU - Ladanyi, M.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84892404851&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000002

DO - 10.1097/JTO.0000000000000002

M3 - Comment/debate

AN - SCOPUS:84892404851

SN - 1556-0864

VL - 8

SP - 1343

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G et al. Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859)). Journal of Thoracic Oncology. 2013;8(10):1343. doi: 10.1097/JTO.0000000000000002